Tumor Prevention Models
Tumor Prevention Models - Related Videos
07:49
Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model
0 Views •
Cited by 15 •
2015
This protocol describes a method for the detailed evaluation of leukocyte subsets within the tumor microenvironment in a mouse tumor model. Chemerin-expressing B16 melanoma cells were implanted subcutaneously into syngeneic mice. Cells from the tumor microenvironment were then stained and analyzed by flow cytometry, allowing for detailed leukocyte subset analyses.
08:31
Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma
0 Views •
2025
This protocol provides a detailed description of the generation, culture, and analysis of mantle cell lymphoma in 3D printed hydrogel tumor slices.
03:17
Preparing Organoids from Tumors: A 3D In Vitro Tumor Model
0 Views •
2023
Organoids derived from tumors are a type of 3D cell culture model that can maintain the pathological features and organ-specific cell lineage of tumors. In the example protocol, we will see scientists generate organoids from a prostate tumor from a genetically engineered mouse model.
06:23
A Murine Orthotopic Bladder Tumor Model and Tumor Detection System
0 Views •
Cited by 8 •
2017
This protocol describes the generation of murine orthotopic bladder tumors in female C57BL/6J mice and the monitoring of tumor growth.
02:43
Tumor Implantation and Injection of a Tumor Vaccine in a Mouse Model
0 Views •
2025
This video demonstrates a cell-based tumor vaccination assay. A mouse, intradermally injected with B16-F10 melanoma cells for tumor formation, is vaccinated with B16-F10 cells secreting Flt3L cytokine near the developed tumor. The secreted Flt3L from the vaccine promotes the maturation and proliferation of dendritic cells that then present tumor antigens to T cells in lymph nodes, triggering a targeted anti-tumor immune response.
FAQs
These models reproduce key stages of carcinogenesis by applying cancer-promoting conditions to cells, tissues, or organisms. Researchers then follow changes that indicate progression, including genetic alterations, abnormal growth, and movement toward malignant behavior. This staged approach helps connect initiating conditions with biological events that occur before an established tumor develops.
Tumor prevention models allow investigators to examine how cancer-promoting conditions trigger genetic changes, abnormal cellular growth, and progression toward malignancy. They also support analysis of biological pathways involved in tumor initiation. Studying these processes can reveal why certain conditions contribute to cancer development and identify pathway changes that may be useful for prevention research.
Cellular, organoid, and animal systems provide complementary experimental settings for examining tumor initiation. Cellular models focus on responses in cells, organoids extend investigation to tissue-like systems, and animal models allow prevention questions to be studied in whole organisms. Comparing findings across these systems can show how consistently a potential intervention works across experimental contexts and cancer types.
Researchers assess genetic changes, abnormal growth, and progression toward malignancy after exposing the experimental system to cancer-promoting conditions. They can compare these findings with results from a prevention strategy to determine whether tumor-related changes are reduced or delayed. These measurements provide evidence about biological response and help evaluate how effectively an intervention works.
A typical investigation exposes cells, tissues, or organisms to cancer-promoting conditions and evaluates a candidate preventive agent within that experimental framework. Researchers measure genetic changes, abnormal growth, and progression toward malignancy, then assess whether the strategy alters those outcomes. The results help identify promising agents and clarify the biological pathways through which prevention may occur.
Researchers may use cellular, organoid, and animal models together when they need to examine prevention findings across multiple levels of biological organization. Results from one system can be assessed in another to determine whether an observed effect remains consistent. This broader evaluation can support biomarker development and inform the design of prevention studies across different cancer types.
By exposing experimental systems to cancer-promoting conditions and tracking subsequent genetic changes, abnormal growth, and progression, researchers can investigate which conditions are associated with tumor initiation. The models provide a controlled way to connect potential risk factors with measurable biological responses. Such findings can guide further prevention research and help prioritize pathways or interventions for study.